{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:03:09Z","timestamp":1761764589098},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1988,1,1]],"date-time":"1988-01-01T00:00:00Z","timestamp":567993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[1988]]},"DOI":"10.1016\/s0002-9149(88)80078-x","type":"journal-article","created":{"date-parts":[[2005,11,30]],"date-time":"2005-11-30T12:14:39Z","timestamp":1133352879000},"page":"9A-13A","source":"Crossref","is-referenced-by-count":33,"title":["Neuroendocrine manifestations of congestive heart failure"],"prefix":"10.1016","volume":"62","author":[{"given":"Gary S.","family":"Francis","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9149(88)80078-X_bib1","first-page":"765","article-title":"Incidence, etiology and prognosis of heart failure","volume":"4","author":"Gorlin","year":"1983","journal-title":"Cardiovasc Rev Rep"},{"key":"10.1016\/S0002-9149(88)80078-X_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.38.4.629","article-title":"Augmented sympathetic neurotransmitter activity in the peripheral vascular bed of patients with congestive heart failure and cardiac norepinephrine depletion","volume":"38","author":"Kramer","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(88)80078-X_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.CIR.58.5.763","article-title":"Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure","volume":"58","author":"Curtiss","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(88)80078-X_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(83)80040-0","article-title":"Increased plasma arginine vasopressin levels in patients with congestive failure","volume":"1","author":"Goldsmith","year":"1983","journal-title":"JACC"},{"key":"10.1016\/S0002-9149(88)80078-X_bib5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-101-3-370","article-title":"The neurohumoral axis in congestive heart failure","volume":"101","author":"Francis","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib6","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-8703(82)90003-5","article-title":"The relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure","volume":"104","author":"Francis","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/S0002-9149(88)80078-X_bib7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0002-9149(82)90243-0","article-title":"Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure","volume":"49","author":"Levine","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0735-1097(86)80417-X","article-title":"Hemodynamic effects of arginine vasopressin in congestive heart failure","volume":"8","author":"Goldsmith","year":"1986","journal-title":"JACC"},{"key":"10.1016\/S0002-9149(88)80078-X_bib9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.2935937","article-title":"Atrial natriuretic peptide elevation in chronic congestive heart failure","volume":"231","author":"Burnett","year":"1986","journal-title":"Science"},{"key":"10.1016\/S0002-9149(88)80078-X_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198402093100603","article-title":"Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia","volume":"310","author":"Dzau","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib11","first-page":"393","article-title":"Free and conjugated plasma catecholamines in patients with congestive heart failure","volume":"103","author":"Francis","year":"1984","journal-title":"J Lab Clin Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib12","series-title":"Drug Therapy of Dilated Cardiomyopathy and Myocarditis","article-title":"Adaptive neurohumoral mechanisms in dilated cardiomyopathy","author":"Francis","year":"1988"},{"key":"10.1016\/S0002-9149(88)80078-X_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9149(78)90162-5","article-title":"Plasma norepinephrine in congestive heart failure","volume":"41","author":"Thomas","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib14","first-page":"444","article-title":"Plasma catecholamines in patients with congestive heart failure","volume":"6","author":"Francis","year":"1984","journal-title":"Cardiovasc Rev Rep"},{"key":"10.1016\/S0002-9149(88)80078-X_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM196309262691302","article-title":"Myocardial norepinephrine concentration in man: effects of reserpine and congestive heart failure","volume":"269","author":"Chidsey","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0002-9149(83)90526-X","article-title":"Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy","volume":"52","author":"Pierpont","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.CIR.67.5.1070","article-title":"The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure","volume":"67","author":"Levine","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(88)80078-X_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM197110142851602","article-title":"Defective cardiac parasympathetic control in patients with heart disease","volume":"285","author":"Eckberg","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0002-9149(86)80034-0","article-title":"Effects of orthotopic heart transplantation on sympathetic control mechanisms in congestive heart failure","volume":"58","author":"Levine","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.me.37.020186.001315","article-title":"The autonomic nervous system in congestive heart failure","volume":"37","author":"Francis","year":"1986","journal-title":"Ann Rev Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0002-9343(63)90118-9","article-title":"Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure","volume":"34","author":"Gaffney","year":"1962","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0002-9149(72)90452-3","article-title":"Pheochromocytoma masquerading as cardiomyopathy","volume":"29","author":"Garcia","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib23","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/0002-9149(86)90991-4","article-title":"Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis","volume":"57","author":"Francis","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-8703(83)90446-5","article-title":"The effects of bromocriptine in patients with congestive heart failure","volume":"106","author":"Francis","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/S0002-9149(88)80078-X_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.44.2.117","article-title":"Beneficial effects of long-term beta blockade in congestive cardiomyopathy","volume":"44","author":"Swedberg","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/S0002-9149(88)80078-X_bib26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/01.CIR.72.3.536","article-title":"Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial","volume":"72","author":"Engelmeier","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(88)80078-X_bib27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJM198207223070401","article-title":"Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts","volume":"307","author":"Bristow","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0167-5273(84)90179-7","article-title":"Myocardial B-adrenergic receptor down-regulation in heart failure","volume":"5","author":"Bristow","year":"1984","journal-title":"Int J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7326\/0003-4819-98-5-603","article-title":"Myocardial performance and extracellular ionized calcium in severely failing human heart","volume":"98","author":"Ginsburg","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-9343(46)90067-8","article-title":"Concentration of renin in renalvenous blood in patients with congestive heart failure","volume":"1","author":"Merrill","year":"1946","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.CIR.25.6.1015","article-title":"Hormones in the pathogenesis of congestive heart failure: vasopressin, aldosterone and angiotensin II","volume":"25","author":"Laragh","year":"1962","journal-title":"Circulation"},{"key":"10.1016\/S0002-9149(88)80078-X_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0002-9343(84)80035-2","article-title":"Vascular wall renin-angiotensin pathway in control of the circulation","volume":"77","author":"Dzau","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib33","first-page":"199","article-title":"Actions of angiotensin on adrenergic nerve endings","volume":"37","author":"Zimmerman","year":"1976"},{"key":"10.1016\/S0002-9149(88)80078-X_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/01.HYP.7.2.253","article-title":"Direct versus indirect pressor and vasoconstrictor actions of angiotensin in conscious dogs","volume":"7","author":"Fujii","year":"1985","journal-title":"Hypertension"},{"key":"10.1016\/S0002-9149(88)80078-X_bib35","first-page":"H167","article-title":"Direct effect of physiologic doses of arginine vasopressin on the arterial wall in vivo","volume":"243","author":"Monos","year":"1978","journal-title":"Am J Physiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1253\/jcj.32.745","article-title":"Plasma ADH levels in patients with chronic congestive heart failure","volume":"32","author":"Yamana","year":"1986","journal-title":"Jpn Circ J"},{"key":"10.1016\/S0002-9149(88)80078-X_bib37","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0002-9149(84)90040-7","article-title":"Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting enzyme blockade","volume":"53","author":"Reigger","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0735-1097(86)80417-X","article-title":"Hemodynamic effects of arginine vasopressin in congestive heart failure","volume":"8","author":"Goldsmith","year":"1986","journal-title":"JACC"},{"key":"10.1016\/S0002-9149(88)80078-X_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0002-9149(85)90743-X","article-title":"Acute hemodynamic effects of a vascular antagonist of vasopressin in patients with congestive heart failure","volume":"55","author":"Nicod","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0735-1097(86)80333-3","article-title":"Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system","volume":"7","author":"Creager","year":"1986","journal-title":"JACC"},{"key":"10.1016\/S0002-9149(88)80078-X_bib41","first-page":"2267","article-title":"Interrelations between vasopressin and the renin-angiotensin system","volume":"38","author":"Share","year":"1979"},{"key":"10.1016\/S0002-9149(88)80078-X_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9149(86)90065-2","article-title":"Arginine vasopressin and the renal response to water loading in congestive heart failure","volume":"58","author":"Goldsmith","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib44","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1210\/endo-114-4-1426","article-title":"The role of central \u03b11 and \u03b12 adrenoreceptors in the regulation of vasopressin release and the cardiovascular system","volume":"114","author":"Kimura","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/S0002-9149(88)80078-X_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9149(83)90078-4","article-title":"Platelet \u03b12 adrenoreceptors in chronic congestive heart failure","volume":"52","author":"Weiss","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0002-9149(86)90846-5","article-title":"Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles","volume":"57","author":"Punzengruber","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1172\/JCI108998","article-title":"Cardiac and renal prostaglandin: biosynthesis and biological effects in isolated perfused rabbit tissues","volume":"61","author":"Needleman","year":"1978","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(88)80078-X_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI110018","article-title":"Participation of the prostaglandins in the control of renal blood flow during acute reduction of cardiac output in the dog","volume":"67","author":"Olivar","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9149(88)80078-X_bib49","first-page":"H305","article-title":"Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins","volume":"323","author":"Blumberg","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0025-7125(16)31503-6","article-title":"Interrelationships among prostaglandins and vasoactive substances","volume":"65","author":"Nasjiletti","year":"1981","journal-title":"Med Clin North Am"},{"key":"10.1016\/S0002-9149(88)80078-X_bib51","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.3006248","article-title":"Inhibition of vasopressin action by atrial natriuretic factor","volume":"231","author":"Dillingham","year":"1986","journal-title":"Science"},{"key":"10.1016\/S0002-9149(88)80078-X_bib52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM198608283150901","article-title":"Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure","volume":"315","author":"Raine","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9149(88)80078-X_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI112723","article-title":"Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion","volume":"78","author":"Cody","year":"1986","journal-title":"J Clin Invest"},{"issue":"suppl I","key":"10.1016\/S0002-9149(88)80078-X_bib54","first-page":"141","article-title":"Vascular and adrenal binding sites for atrial natriuretic factor: effects of sodium and hypertension","volume":"8","author":"Schiffrin","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/S0002-9149(88)80078-X_bib55","doi-asserted-by":"crossref","first-page":"15A","DOI":"10.1016\/0002-9149(85)90791-X","article-title":"Neurohumoral mechanisms involved in heart failure","volume":"55","author":"Francis","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0002-9149(88)80078-X_bib56","first-page":"70A","article-title":"Acute hemodynamic response to oral fenoldopam, a dopamine receptor agonist, in chronic congestive heart failure","volume":"7","author":"Wilson","year":"1986","journal-title":"JACC"},{"key":"10.1016\/S0002-9149(88)80078-X_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.2990050","article-title":"Vasopressin stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis","volume":"229","author":"Manning","year":"1985","journal-title":"Science"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291498880078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291498880078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T05:15:10Z","timestamp":1576214110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291498880078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988]]}},"alternative-id":["S000291498880078X"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9149(88)80078-x","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[1988]]}}}